Two unconnected drug discovery initiatives unveiled on Wednesday provide further evidence of Germany’s ongoing strengths in the chemical and biological disciplines underpinning modern drug discovery, notwithstanding an ongoing lack of confidence in the area on the part of the country’s investors.